Ozagrel Sodium

奥扎格雷钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOzagrel Sodium
Drug Alias Name丹奥XanbonXanbonSCataclotKCT-0809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 synthase inhibitors
TargetsThromboxane A2 synthase
Therapy Area/IndicationsSjogren-Larsson SyndromeDry Eye SyndromesCerebrovascular Disorders
Global Approved IndicationsCerebrovascular Disorders
Approved Indications in ChinaCerebrovascular Disorders
Original Approved Country/TerritoryJapan
Original Approved Date1988/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsCerebrovascular Disorders
Inactive IndicationsSjogren-Larsson SyndromeDry Eye Syndromes

Other Information

ATC CodeC
Related LinksWikipediaKEGG